These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 14671173

  • 1. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [Abstract] [Full Text] [Related]

  • 2. Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus.
    Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):225-9. PubMed ID: 17547690
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [Abstract] [Full Text] [Related]

  • 4. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M, Elias LL, Elias PC, Moreira AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [Abstract] [Full Text] [Related]

  • 5. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P, Bertolini M, Losa M, Cavagnini F.
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [Abstract] [Full Text] [Related]

  • 6. Cushing's syndrome in a clinic population with diabetes.
    Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE.
    Intern Med J; 2008 Mar; 38(3):178-82. PubMed ID: 17645502
    [Abstract] [Full Text] [Related]

  • 7. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 8. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L.
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [Abstract] [Full Text] [Related]

  • 9. Screening for subclinical Cushing's syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol.
    Gagliardi L, Chapman IM, O'Loughlin P, Torpy DJ.
    Horm Metab Res; 2010 Apr; 42(4):280-4. PubMed ID: 20119887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [Abstract] [Full Text] [Related]

  • 15. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients.
    Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):717-22. PubMed ID: 8759185
    [Abstract] [Full Text] [Related]

  • 16. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F, Boscaro M.
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [Abstract] [Full Text] [Related]

  • 17. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B, Chabre O, Cortet C, Martinie M, Corcuff JB, Roger P, Tabarin A.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [Abstract] [Full Text] [Related]

  • 18. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.
    Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):878-82. PubMed ID: 10084565
    [Abstract] [Full Text] [Related]

  • 19. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C, Alford FP, Topliss DJ, Burgess JR, Long F, Gome JJ, Stockigt JR, Inder WJ.
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
    [Abstract] [Full Text] [Related]

  • 20. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
    Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M, Disoteo O, Ambrosi B, Lanzi R, Arosio M, Senni S, Balestrieri A, Solaroli E, Madeo B, De Giovanni R, Strollo F, Battista R, Scorsone A, Giagulli VA, Collura D, Scillitani A, Cozzi R, Faustini-Fustini M, Pia A, Rinaldi R, Allasino B, Peraga G, Tassone F, Garofalo P, Papini E, Borretta G.
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3467-75. PubMed ID: 22767639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.